ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,492, issued on April 7, was assigned to Seattle Children's Hospital (Seattle).
"Rapamycin resistant cells" was invented by Andrew M. Scharenberg (Seattle), David J. Rawlings (Seattle), Karen Sommer (Seattle), Samuel West (Seattle), Yuchi Chiang Honaker (Seattle) and Ryo Takeuchi (Seattle).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present application relates to, inter alia, compositions including proteins for expression in host cells to render them resistant to rapamycin. The application further relates to methods of using the proteins, cells, and compositions disclosed therein for modulating cell signaling and for selective expansion of cell...